ISPOR is coming to Canada this year, taking place in Montreal, May 5th to 8th. Broadstreet is pleased to be involved in six studies being presented on subjects ranging from…

Broadstreet is very pleased to be welcoming an old friend and new vice president to the team, Suzanne McMullen. She has known Shelagh and Karissa since the early days of…

ISPOR Europe is returning to Barcelona this year and Broadstreet is pleased to be there with six studies to present on subjects ranging from patient preferences for early oncology trial…

A few weeks ago, the National Institute for Health and Care Excellence (NICE) released a position statement on the use of Artificial Intelligence (AI) in evidence generation. Their announcement came…

Complex data and scientific evidence are the currency of health economics and outcomes research (HEOR), and technical tools have always played a role in how we investigate value and access…

Asthma affects more than 4 million Canadians, making it the third most common chronic condition in the country.(Government of Canada 2024) Between 5-10% of those 4 million+ have severe asthma.(Chung,…

Spinocerebellar ataxias (SCA) are rare inherited neurodegenerative disorders marked by increasing issues with gait, balance, limb coordination, and speech. At present, there is no scale available for measuring the progression…

ISPOR US is moving south this year, taking place in Atlanta, May 5th to 8th. Broadstreet is pleased to be involved in twelve studies being presented on subjects ranging from…

ISPOR US is moving south this year, taking place in Atlanta, May 5th to 8th. Broadstreet is pleased to be involved in twelve studies being presented on subjects ranging from…

February 29th is Rare Disease Day; rare diseases affect fewer than 1 in 2,000 people,1 while ultra-rare diseases affect fewer than 1 in 50,000 people.2 Globally, around 300 million people…